Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992215178> ?p ?o ?g. }
- W1992215178 endingPage "827" @default.
- W1992215178 startingPage "827" @default.
- W1992215178 abstract "Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus Candis M Morello1,21Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 2School of Pharmacy, University of California San Francisco, Veterans Affairs San Diego Healthcare System, San Diego, CA, USAIntroduction: The goal of insulin therapy in patients with either type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) is to match as closely as possible normal physiologic insulin secretion to control fasting and postprandial plasma glucose. Modifications of the insulin molecule have resulted in two long-acting insulin analogs (glargine and detemir) and three rapid-acting insulins (aspart, lispro, and glulisine) with improved pharmacokinetic/pharmacodynamic (PK/PD) profiles. These agents can be used together in basal-bolus therapy to more closely mimic physiologic insulin secretion patterns.Methods: This study reviews effects of the multiple demographic and clinical parameters in the insulin analogs glargine, detemir, lispro, aspart, and glulisine in patients with T2DM. A search was conducted on PubMed for each major topic considered (effects of injection site, age, race/ethnicity, obesity, renal or hepatic dysfunction, pregnancy, exercise, drug interactions) using the topic words and name of each type of insulin analog. Information was also obtained from the prescribing information for each insulin analog.Results: The PK/PD profiles for insulin analogs may be influenced by many variables including age, weight, and hepatic and renal function. However, these variables do not have equivalent effects on all long-acting or rapid-acting insulin analogs.Conclusion: Rapid-acting and long-acting insulin analogs represent major advances in treatment for patients with T2DM who require insulin therapy. However, there are potentially important PK and PD differences between the two long-acting agents and among the three rapid-acting insulin analogs, which should be considered when designing treatment regimens for special patient groups.Keywords: insulin analogs, type 2 diabetes mellitus, pharmacodynamics, pharmacokinetics" @default.
- W1992215178 created "2016-06-24" @default.
- W1992215178 creator A5051986130 @default.
- W1992215178 date "2011-12-01" @default.
- W1992215178 modified "2023-09-26" @default.
- W1992215178 title "Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus" @default.
- W1992215178 cites W1495771839 @default.
- W1992215178 cites W1534052272 @default.
- W1992215178 cites W1964773646 @default.
- W1992215178 cites W1967649339 @default.
- W1992215178 cites W1969035921 @default.
- W1992215178 cites W1971027046 @default.
- W1992215178 cites W1986702000 @default.
- W1992215178 cites W1990481258 @default.
- W1992215178 cites W1995276446 @default.
- W1992215178 cites W1999246346 @default.
- W1992215178 cites W2001320833 @default.
- W1992215178 cites W2001636022 @default.
- W1992215178 cites W2014887370 @default.
- W1992215178 cites W2020214777 @default.
- W1992215178 cites W2023350135 @default.
- W1992215178 cites W2039195100 @default.
- W1992215178 cites W2042963237 @default.
- W1992215178 cites W2043362163 @default.
- W1992215178 cites W2043454334 @default.
- W1992215178 cites W2054896794 @default.
- W1992215178 cites W2063914338 @default.
- W1992215178 cites W2070818248 @default.
- W1992215178 cites W2074102855 @default.
- W1992215178 cites W2076457002 @default.
- W1992215178 cites W2089774478 @default.
- W1992215178 cites W2090664574 @default.
- W1992215178 cites W2093774827 @default.
- W1992215178 cites W2104100987 @default.
- W1992215178 cites W2108646121 @default.
- W1992215178 cites W2109222432 @default.
- W1992215178 cites W2110482601 @default.
- W1992215178 cites W2126781806 @default.
- W1992215178 cites W2127854940 @default.
- W1992215178 cites W2129121181 @default.
- W1992215178 cites W2130931445 @default.
- W1992215178 cites W2131656660 @default.
- W1992215178 cites W2133057011 @default.
- W1992215178 cites W2134788098 @default.
- W1992215178 cites W2137415633 @default.
- W1992215178 cites W2141530990 @default.
- W1992215178 cites W2150531009 @default.
- W1992215178 cites W2150939399 @default.
- W1992215178 cites W2155918752 @default.
- W1992215178 cites W2161252140 @default.
- W1992215178 cites W2162274810 @default.
- W1992215178 cites W2168648115 @default.
- W1992215178 cites W2298889396 @default.
- W1992215178 cites W2321912191 @default.
- W1992215178 cites W2402579387 @default.
- W1992215178 cites W2615893259 @default.
- W1992215178 cites W2734011609 @default.
- W1992215178 cites W2069218619 @default.
- W1992215178 doi "https://doi.org/10.2147/ijgm.s26889" @default.
- W1992215178 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3258012" @default.
- W1992215178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22267935" @default.
- W1992215178 hasPublicationYear "2011" @default.
- W1992215178 type Work @default.
- W1992215178 sameAs 1992215178 @default.
- W1992215178 citedByCount "54" @default.
- W1992215178 countsByYear W19922151782012 @default.
- W1992215178 countsByYear W19922151782013 @default.
- W1992215178 countsByYear W19922151782014 @default.
- W1992215178 countsByYear W19922151782015 @default.
- W1992215178 countsByYear W19922151782016 @default.
- W1992215178 countsByYear W19922151782017 @default.
- W1992215178 countsByYear W19922151782018 @default.
- W1992215178 countsByYear W19922151782019 @default.
- W1992215178 countsByYear W19922151782020 @default.
- W1992215178 countsByYear W19922151782021 @default.
- W1992215178 countsByYear W19922151782022 @default.
- W1992215178 countsByYear W19922151782023 @default.
- W1992215178 crossrefType "journal-article" @default.
- W1992215178 hasAuthorship W1992215178A5051986130 @default.
- W1992215178 hasBestOaLocation W19922151781 @default.
- W1992215178 hasConcept C104863432 @default.
- W1992215178 hasConcept C111113717 @default.
- W1992215178 hasConcept C112705442 @default.
- W1992215178 hasConcept C126322002 @default.
- W1992215178 hasConcept C134018914 @default.
- W1992215178 hasConcept C2776486108 @default.
- W1992215178 hasConcept C2776664568 @default.
- W1992215178 hasConcept C2777180221 @default.
- W1992215178 hasConcept C2778199505 @default.
- W1992215178 hasConcept C2779306644 @default.
- W1992215178 hasConcept C2779908123 @default.
- W1992215178 hasConcept C2779920387 @default.
- W1992215178 hasConcept C2780677441 @default.
- W1992215178 hasConcept C2781232474 @default.
- W1992215178 hasConcept C2910068830 @default.
- W1992215178 hasConcept C3019948211 @default.
- W1992215178 hasConcept C512399662 @default.
- W1992215178 hasConcept C555293320 @default.